Second Line Treatment
13 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Dose Escalation Study of Cabozantinib for Advanced HCC Patients With Preserved Liver Function (NCT04522908) | Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest | 2020-10-12 |
| A Study of Second-line Treatment With Apatinib in Patients With Advanced Intrahepatic Cholangiocarcinoma (NCT03251443) | Peking Union Medical College Hospital | 2017-08-08 |
| Real-world Data of Paclitaxel and Ramucirumab Compared to Other Treatment Regimens in Advanced Gastric Cancer (NCT06666582) | Hellenic Cooperative Oncology Group | 2015-03-01 |
| A Phase II Study to Evaluate the Efficacy of TKI258 for the Treatment of Patients With FGFR2 Mutated or Wild-type Advanced and/or Metastatic Endometrial Cancer (NCT01379534) | Novartis Pharmaceuticals | 2011-11-01 |
Track Second Line Treatment automatically
Every clearance here is in the API, with alerts when new ones post.